Abstract
We report the case of a 42 year-old woman withmyasthenia gravis associated with a malignant thymoma. Despite surgery, chemotherapy and radiotherapy, the thymoma showed soft tissues, pleural and mediastinic progression. Unexpectedly, a complete remission of the thymoma was confirmed by FDG-PET after four cycles of immunoglobulins, administered as treatment for a myasthenic crisis, To our knowledge this is the first case report of complete remission of a malignant thymoma with immunoglobulin therapy.
Similar content being viewed by others
References
Schmidt-Wolf IG, Rockstroh JK, Schuller H, et al. Malignant thymoma: current status of classification and multimodality treatment, Ann Hematol. 2005;82:69–76.
Levy Y, Afek A, Sherer Y, et al. Malignant thymoma associated with autoimmune diseases: a retrospective study and review of the literature. Semin Arthritis Rheum. 1998;28:73–9.
Thomas CR, Wright CD, Loehrer PJ. Thymoma: state of the art. J Clin Oncol. 1999; 17:2280–9.
Hoffacker V, Schultz A, Tiesinga JJ, et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease. Blood. 2000;96:3872–9.
Buckley C, Douek D, Newsom-Davis J, Vincent A, Willcox N. Mature, long-lived CD4+ and CD8+ T cells are generated by the thymoma in myasthenia gravis. Ann Neurol. 2001;50:64–72.
Larroche C, Mouthon L, Casadevall N, Le Roux G, Casassus P, Guillevin L. Successful treatment of thymoma-associated pure red cell aplasia with intravenous immunoglobulins. Eur J Haematol. 2000:65:74–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Murie-Fernández, M., Gurpide, A., de la Cruz, S. et al. Total remission of thymus carcinoma after treatment with intravenous immunoglobulin. Clin Transl Oncol 8, 697–699 (2006). https://doi.org/10.1007/s12094-006-0043-7
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s12094-006-0043-7